Clinical Trials Logo

Syndrome clinical trials

View clinical trials related to Syndrome.

Filter by:

NCT ID: NCT04967144 Completed - Clinical trials for Carpal Tunnel Syndrome

Carpal Tunnel Syndrome, Right/Left Judgement

Start date: July 19, 2021
Phase:
Study type: Observational

The discrimination of the right/left side of the body is related to the integrity of the motor and somatosensory areas at the cortical and subcortical levels. Although some studies have shown that there may be an effect on the right/left representation at the cortical and subcortical levels in cases that cause severe neuropathy and neuropathic pain, this effect has not been proven in milder neuropathies. In this study, the effect on right/left side discrimination will be investigated even in cases with carpal tunnel syndrome. Additionally, the investigators aimed to assess the relationship between right/left discrimination and symptom severity.

NCT ID: NCT04966780 Completed - Acute Abdomen Clinical Trials

Refeeding Like Syndrome in Acute Disease

RLS
Start date: April 1, 2018
Phase:
Study type: Observational

The refeeding syndrome has been reported without any evidence of prolopnged semistarvation, thus being different from the traditional disease. The investigators wanted to investigate, if sodium infusions could be part of the explanation.

NCT ID: NCT04966403 Completed - Down Syndrome Clinical Trials

Effects of Stretch-shortening Cycle Exercises Postural Control in Down Syndrome

Start date: December 1, 2018
Phase: N/A
Study type: Interventional

To investigate the effect of a 3-month, trampoline-based stretch-shortening cycle (SSC) exercises on muscle strength and postural control in children with Down syndrome.

NCT ID: NCT04964986 Completed - Clinical trials for Short Bowel Syndrome

Metabolic Balance Study of Apraglutide in Patients With SBS-IF and Colon-in-Continuity

STARSnutrition
Start date: June 14, 2021
Phase: Phase 2
Study type: Interventional

The primary objective of the trial is to evaluate the safety of apraglutide in adult subjects with SBS-IF and CIC.

NCT ID: NCT04961476 Completed - Covid19 Clinical Trials

Use of 1-MNA to Improve Exercise Tolerance and Fatigue in Patients After COVID-19

Start date: January 8, 2021
Phase:
Study type: Observational [Patient Registry]

Coronavirus disease 2019 (COVID-19) is a serious respiratory disease that results from infection with a newly discovered coronavirus (SARS-COV-2). Unfortunately, COVID-19 is not only a short-term infection but that patients (pts) recovering from SARS-COV2 infection complain of persisting symptoms including: fatigue, diffuse myalgia and weakness, which may lead to chronic fatigue syndrome. There is currently no evidence that nutritional supplements and/or physical exercise can assist in the recovery of pts with chronic fatigue syndrome. 1-Methylnicotinamide (1-MNA) is an endogenic substance that is produced in the liver when nicotinic acid is metabolized. 1-MNA demonstrates anti-inflammatory and anti-thrombotic properties. Therefore, we investigated whether 1-MNA supplements could improve exercise tolerance and decrease fatigue among patients recovering from SARS-COV-2.

NCT ID: NCT04961281 Completed - Chronic Pain Clinical Trials

Dexmedetomidine Versus Triamcinolone Treatment of Carpal Tunnel Syndrome

Start date: July 22, 2021
Phase: N/A
Study type: Interventional

Carpal tunnel syndrome (CTS) is a common mononeuropathy due to entrapment of the median nerve in the carpal tunnel. a lot of modaleties are available for treatment of mild to moderate CTS.

NCT ID: NCT04960605 Completed - Dental Implant Clinical Trials

Prognosis of Dental Implants in Patients With Primary Sjögren's Syndrome

Start date: January 1, 2015
Phase: N/A
Study type: Interventional

Primary Sjögren's Syndrome (PSS) is a chronic autoimmune inflammatory disease primarily involving the salivary and lacrimal glands. Few data exist regarding survival and success rate of dental implants in patients with PSS. Although a previous study suggest lower success rate for dental implants we hypothesize that dental implants have similar survival and success rate in PSS as healthy controls. The purpose of the present study was to evaluate the long-term survival and success rate of dental implants in patients with PSS compared to the healthy controls.

NCT ID: NCT04958603 Completed - Clinical trials for Lateral Patellar Compression Syndrome

The Clinical Effect of Different Lateral Retinaculum Relaxation Methods in the Treatment of LPCS

Start date: April 1, 2020
Phase:
Study type: Observational

To observe the comparison of the clinical effects of two different ways of loosening the lateral support band under arthroscopy to treat lateral patella excessive compression syndrome.

NCT ID: NCT04956757 Completed - Clinical trials for Rotator Cuff Impingement Syndrome

Scapula Retraction Exercises in Subacromial Pain Syndrome

Start date: July 30, 2021
Phase: N/A
Study type: Interventional

Scapula retraction exercises are often recommended as a part of the exercise programs. The primary aim of this study is to investigate the initial effect of the scapula retraction exercises on acromiohumeral distance (AHD) at varying shoulder abduction angles and to compare asymptomatic subjects. The secondary aim of this study is to investigate the effect of scapula retraction exercises on AHD values and symptoms (pain and disability) in patients with SPS.

NCT ID: NCT04954755 Completed - Clinical trials for Development and Validation of a Prediction Model for Refeeding Syndrome in ICU Patients Undergoing Enteral Nutrition

Development and Validation of a Prediction Model for Refeeding Syndrome in ICU Patients Undergoing Enteral Nutrition Patients

RFS
Start date: December 1, 2019
Phase:
Study type: Observational

This study intends to strengthen the discussion on the risk factors of RFS in critically ill patients, and construct an RFS risk prediction model which is easy for clinical medical staff to use and has a high sensitivity and specificity; In order to help medical staff to identify the high-risk groups of RFS in critically ill patients efficiently and accurately, and take targeted care and treatment for patients, so as to reduce the adverse consequences of RFS on critically ill patients.